Open Access

This article has an erratum: []

J Oral Med Oral Surg
Volume 29, Number 3, 2023
Article Number 27
Number of page(s) 13
Published online 17 August 2023
  1. Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders, 3rd ed. (beta version). Cephalalgia. 2013;33:629-808. [CrossRef] [PubMed] [Google Scholar]
  2. Zakrzewska J, Glenny A, Forssell H. Interventions for the treatment of burning mouth syndrome. In: The Cochrane Collaboration. Cochrane Database of Systematic Reviews [Internet. Chichester, UK: John Wiley & Sons, Ltd; 2000. p. CD002779. [Google Scholar]
  3. Grushka M, Ching V, Epstein J. Burning Mouth Syndrome. In: HummelT,Welge-Lüssen A, Eds. Advances in oto-rhino-laryngology. Basel: KARGER 2006:278-287. [CrossRef] [PubMed] [Google Scholar]
  4. Scala A, Checchi L, Montevecchi M, Marini I, Giamberardino MA. Update on burning mouth syndrome: overview and patient management. Crit Rev Oral Biol Med 2003;14:275-291. [CrossRef] [PubMed] [Google Scholar]
  5. Werfalli S, Drangsholt M, Johnsen JM, Jeffrey SK, Dakhil S, Presland RB, et al. Saliva flow rates and clinical characteristics of patients with burning mouth syndrome: a case–control study. Int J Oral Maxillofac Surg 2021;50:1187-1194. [CrossRef] [PubMed] [Google Scholar]
  6. Imura H, Shimada M, Yamazaki Y, Sugimoto K. Characteristic changes of saliva and taste in burning mouth syndrome patients. J Oral Pathol Med 2016;45:231-236. [CrossRef] [PubMed] [Google Scholar]
  7. Lopez-Jornet P, Castillo Felipe C, Pardo-Marin L, Ceron JJ,Pons-Fuster E, Tvarijonaviciute A. Salivary biomarkers and their correlation with pain and stress in patients with burning mouth syndrome. JCM 2020;9:929. [CrossRef] [Google Scholar]
  8. López-Jornet P, Juan H, Alvaro PF. Mineral and trace element analysis of saliva from patients with BMS: a cross-sectional prospective controlled clinical study. J Oral Pathol Med 2014;43:111-1116. [CrossRef] [PubMed] [Google Scholar]
  9. Nosratzehi T, Salimi S, Parvaee A. Comparison of Salivary Cortisol and α-amylase levels and psychological profiles in patients with burning mouth syndrome: salivary cortisol and A-amylase levels in burning mouth syndrome. Spec Care Dentist 2017;37:120‑125. [CrossRef] [PubMed] [Google Scholar]
  10. Kim HI, Kim YY, Chang JY, Ko JY, Kho HS. Salivary cortisol, 17β-estradiol, progesterone, dehydroepiandrosterone, and α-amylase in patients with burning mouth syndrome: salivary steroid and α-amylase in burning mouth syndrome. Oral Dis 2012;18:613‑620. [CrossRef] [PubMed] [Google Scholar]
  11. Acharya S, Jin C, Bylund J, Shen Q, Kamali-Moghaddam M, Jontell M, et al. Reduced sialyl-Lewis x on salivary MUC7 from patients with burning mouth syndrome. Mol Omics 2019;15:331‑339. [CrossRef] [PubMed] [Google Scholar]
  12. Boras Vv, Savage Nw, Brailo V, Lukac J, Lukac M, Alajbeg Iz. Salivary and serum levels of substance p, neurokinin A and calcitonin gene related peptide in burning mouth syndrome. Med Oral 2010;e427–e431. [CrossRef] [Google Scholar]
  13. Moura SAB de, Sousa JMA de, Lima DF, Negreiros AN do M, Silva F de V, Costa LJ da. Burning mouth syndrome (BMS): sialometric and sialochemical analysis and salivary protein profile. Gerodontology 2007;24:173–176. [CrossRef] [PubMed] [Google Scholar]
  14. Aitken-Saavedra J, Tarquinio S, da Rosa Wo, Gomes A, da Silva A,Fernandez Ms, et al. Salivary characteristics may be associated with burning mouth syndrome? J Clin Exp Dent 2021;e542–e548. [CrossRef] [PubMed] [Google Scholar]
  15. Amenábar JM, Pawlowski J, Hilgert JB, Hugo FN, Bandeira D, Lhüller F, et al. Anxiety and salivary cortisol levels in patients with burning mouth syndrome: case–control study. Oral Surg Oral Med Oral Pathol Oral Radiol Endodontol 2008;105:460–465. [CrossRef] [Google Scholar]
  16. Hershkovich O, Nagler RM. Biochemical analysis of saliva and taste acuity evaluation in patients with burning mouth syndrome, xerostomia and/or gustatory disturbances. Arch Oral Biol 2004;49:515–522. [CrossRef] [PubMed] [Google Scholar]
  17. Henkin RI, Gouliouk V, Fordyce A. Distinguishing patients with glossopyrosis from those with oropyrosis based upon clinical differences and differences in saliva and erythrocyte magnesium. Arch Oral Biol 2012;57:205–210. [CrossRef] [PubMed] [Google Scholar]
  18. Pekiner FN, Gümrü B, Demirel GY, Özbayrak S. Burning mouth syndrome and saliva: detection of salivary trace elements and cytokines: Salivary trace elements and cytokines in BMS. J Oral Pathol Med. 2009;38:269–275. [CrossRef] [PubMed] [Google Scholar]
  19. Borelli V, Marchioli A, Di Taranto R, Romano M, Chiandussi S, Di Lenarda R, et al. Neuropeptides in saliva of subjects with burning mouth syndrome: a pilot study. Oral Dis 2010;16:365–374. [CrossRef] [PubMed] [Google Scholar]
  20. Suh KI, Kim YK, Kho HS. Salivary levels of IL-1β, IL-6, IL-8, and TNF-α in patients with burning mouth syndrome. Arch Oral Biol 2009;54:797–802. [CrossRef] [PubMed] [Google Scholar]
  21. Salarić I, Sabalić M, Alajbeg I. Opiorphin in burning mouth syndrome patients: a case–control study. Clin Oral Investig 2017;21:2363–2370. [CrossRef] [PubMed] [Google Scholar]
  22. Boucher Y, Braud A, Dufour E, Agbo-Godeau S, Baaroun V, Descroix V, et al. Opiorphin levels in fluids of burning mouth syndrome patients: a case–control study. Clin Oral Invest 2017;21:2157–2164. [CrossRef] [PubMed] [Google Scholar]
  23. Zidverc-Trajkovic J, Stanimirovic D, Obrenovic R, Tajti J, Vécsei L,Gardi J, et al. Calcitonin gene-related peptide levels in saliva of patients with burning mouth syndrome: CGRP in saliva of patients with BMS. J Oral Pathol Med 2008;38:29–33. [CrossRef] [Google Scholar]
  24. de Souza FTA, Kummer A, Silva MLV, Amaral TMP, Abdo EN, Abreu MHNG, et al. The association of openness personality trait with stress-related salivary biomarkers in burning mouth syndrome. Neuroimmunomodulation. 2015;22:250–255. [CrossRef] [PubMed] [Google Scholar]
  25. Ji EH, Diep C, Liu T, Li H, Merrill R, Messadi D, et al. Potential protein biomarkers for burning mouth syndrome discovered by quantitative proteomics. Mol Pain 2017;13:174480691668679. [CrossRef] [Google Scholar]
  26. Simcic D, Pezelj-Ribaric S, Gržic R, Horvat J, Brumini G, Muhvic-Urek M. Detection of Salivary Interleukin 2 and Interleukin 6 in Patients With Burning Mouth Syndrome. Mediators Inflam 2006;2006:1–4. [CrossRef] [Google Scholar]
  27. Srinivasan M, Kodumudi KN, Zunt SL. Soluble CD14 and toll-like receptor-2 are potential salivary biomarkers for oral lichen planus and burning mouth syndrome. Clin Immunol 2008;126: 31– 37. [CrossRef] [PubMed] [Google Scholar]
  28. Lončar-Brzak B, Vidranski V, Andabak-Rogulj A, Vidović-Juras D, Todorić-Laidlaw I, Gabrić D, et al. Salivary hormones and quality of life in female postmenopausal burning mouth patients—a pilot case-control study. Dentistry J 2020;8:111. [CrossRef] [Google Scholar]
  29. Shigeyama-Haruna C, Soh I, Yoshida A, Awano S, Anan H, Ansai T. Salivary levels of cortisol and chromogranin A in patients with burning mouth syndrome: a case-control study. OJST 2013;03: 39– 43. [CrossRef] [Google Scholar]
  30. Fernandes CSD, Salum FG, Bandeira D, Pawlowski J, Luz C, Cherubini K. Salivary dehydroepiandrosterone (DHEA) levels in patients with the complaint of burning mouth: a case-control study. Oral Surg Oral Med Oral Pathol Oral Radiol Endodontol 2009;108:537– 543. [CrossRef] [Google Scholar]
  31. Glick D, Ben-Aryeh H, Gutman D, Szargel R. Relation between idiopathic glossodynia and salivary flow rate and content. International J Oral Surg 1976;5:161– 165. [CrossRef] [Google Scholar]
  32. Loeb LM, Naffah-Mazzacoratti MG, Porcionatto MA, Martins JRM, Kouyoumdjian M, Weckx LM, et al. Chondroitin sulfate and kallikrein in saliva: markers for glossodynia. Int Immunopharmacol 2008;8:1056– 1058. [CrossRef] [PubMed] [Google Scholar]
  33. Tvarijonaviciute A, Aznar-Cayuela C, Rubio CP, Ceron JJ, López-Jornet P. Evaluation of salivary oxidate stress biomarkers, nitric oxide and C-reactive protein in patients with oral lichen planus and burning mouth syndrome. J Oral Pathol Med 2017;46:387–392. [CrossRef] [PubMed] [Google Scholar]
  34. Tammiala-Salonen T, Söderling E. Protein composition, adhesion, and agglutination properties of saliva in burning mouth syndrome. Eur J Oral Sci 1993;101:215–218. [CrossRef] [Google Scholar]
  35. Kaczor-Urbanowicz KE, Martin Carreras-Presas C, Aro K, Tu M,Garcia-Godoy F, Wong DT. Saliva diagnostics − current views and directions. Exp Biol Med (Maywood) 2017;242:459–472. [CrossRef] [PubMed] [Google Scholar]
  36. Braud A, Boucher Y. The relationship between the clinical features of idiopathic burning mouth syndrome and self-perceived quality of life. J Oral Scie 2016;58:475– 481. [CrossRef] [PubMed] [Google Scholar]
  37. Moura B de S, Ferreira N dos R, DosSantos MF, Janini MER. Changes in the vibration sensitivity and pressure pain thresholds in patients with burning mouth syndrome. PLoS ONE 2018;13:e0197834. [CrossRef] [PubMed] [Google Scholar]
  38. Navazesh M. Methods for collecting saliva. Ann NY Acad Sci 1993;694:72– 77. [CrossRef] [PubMed] [Google Scholar]
  39. Navazesh M, Kumar SKS. Measuring salivary flow. J Am Dent Assoc 2008;139:35S–40S. [CrossRef] [PubMed] [Google Scholar]
  40. Nunes LAS, Brenzikofer R, Macedo DV. Reference intervals for saliva analytes collected by a standardized method in a physically active population. Clin Biochem 2011;44:1440– 1444. [CrossRef] [PubMed] [Google Scholar]
  41. Kang JH, Kho HS. Blood contamination in salivary diagnostics: current methods and their limitations. Clin Chem Lab Med 2019;57:1115– 1124. [CrossRef] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.